A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer (Q34106382)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer |
scientific article |
Statements
1 reference
A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer (English)
1 reference
Keith D Wilner
1 reference
Eric B Haura
1 reference
Alejandro D Ricart
1 reference
Timothy G Larson
1 reference
Philip J Stella
1 reference
Lyudmila Bazhenova
1 reference
Vincent A Miller
1 reference
Roger B Cohen
1 reference
Peter D Eisenberg
1 reference
Paulina Selaru
1 reference
Shirish M Gadgeel
1 reference
23 March 2010
1 reference
1 reference
16
1 reference
2450-2457
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference